The all -
day meeting showcased the work of more than 100 experts from academia, federal and regulatory agencies, government research agencies, pharmaceutical and biotech industry, and patient advocacy community who have worked
together over the
past several months to prepare draft consensus recommendations on how to address the regulatory issues around HIV cure research.